167 related articles for article (PubMed ID: 10499723)
21. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
[TBL] [Abstract][Full Text] [Related]
22. Mast cells in canine cutaneous hemangioma, hemangiosarcoma and mammary tumors.
Woldemeskel M; Rajeev S
Vet Res Commun; 2010 Feb; 34(2):153-60. PubMed ID: 20127412
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Significance of Canine Mammary Tumor Histologic Subtypes: An Observational Cohort Study of 229 Cases.
Rasotto R; Berlato D; Goldschmidt MH; Zappulli V
Vet Pathol; 2017 Jul; 54(4):571-578. PubMed ID: 28355108
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors in canine mammary tumors: a multivariate study of 202 consecutive cases.
Hellmén E; Bergström R; Holmberg L; Spångberg IB; Hansson K; Lindgren A
Vet Pathol; 1993 Jan; 30(1):20-7. PubMed ID: 8442324
[TBL] [Abstract][Full Text] [Related]
25. COX-2 over-expression correlates with VEGF and tumour angiogenesis in canine mammary cancer.
Queiroga FL; Pires I; Parente M; Gregório H; Lopes CS
Vet J; 2011 Jul; 189(1):77-82. PubMed ID: 20675158
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of regional lymph node status in canine mammary carcinomas.
Szczubiał M; Łopuszynski W
Vet Comp Oncol; 2011 Dec; 9(4):296-303. PubMed ID: 22077411
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical expression of vascular endothelial growth factor in canine mammary tumours.
Santos AA; Oliveira JT; Lopes CC; Amorim IF; Vicente CM; Gärtner FR; Matos AJ
J Comp Pathol; 2010 Nov; 143(4):268-75. PubMed ID: 20570280
[TBL] [Abstract][Full Text] [Related]
28. Magnetic resonance imaging technique for the examination of canine mammary tumours.
Garamvölgyi R; Petrási Z; Hevesi A; Jakab C; Vajda Z; Bogner P; Repa I
Acta Vet Hung; 2006 Jun; 54(2):143-59. PubMed ID: 16841753
[TBL] [Abstract][Full Text] [Related]
29. Increased levels of interleukins 8 and 10 as findings of canine inflammatory mammary cancer.
de Andrés PJ; Illera JC; Cáceres S; Díez L; Pérez-Alenza MD; Peña L
Vet Immunol Immunopathol; 2013 Apr; 152(3-4):245-51. PubMed ID: 23351639
[TBL] [Abstract][Full Text] [Related]
30. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.
Carvalho MI; Pires I; Prada J; Lobo L; Queiroga FL
Vet Pathol; 2016 Nov; 53(6):1138-1146. PubMed ID: 27162119
[TBL] [Abstract][Full Text] [Related]
31. HER-2, EGFR, Cox-2 and Ki67 expression in lymph node metastasis of canine mammary carcinomas: Association with clinical-pathological parameters and overall survival.
Araújo MR; Campos LC; Damasceno KA; Gamba CO; Ferreira E; Cassali GD
Res Vet Sci; 2016 Jun; 106():121-30. PubMed ID: 27234549
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of immunohistochemical markers of lymphatic and blood vessels in canine mammary tumours.
Sleeckx N; Van Brantegem L; Fransen E; Van den Eynden G; Casteleyn C; Veldhuis Kroeze E; Van Ginneken C
J Comp Pathol; 2013 May; 148(4):307-17. PubMed ID: 23123127
[TBL] [Abstract][Full Text] [Related]
33. Immunohistologic detection of estrogen receptor alpha in canine mammary tumors: clinical and pathologic associations and prognostic significance.
Nieto A; Peña L; Pérez-Alenza MD; Sánchez MA; Flores JM; Castaño M
Vet Pathol; 2000 May; 37(3):239-47. PubMed ID: 10810988
[TBL] [Abstract][Full Text] [Related]
34. Correlation of vascular endothelial growth factor expression to overall survival in feline invasive mammary carcinomas.
Millanta F; Lazzeri G; Vannozzi I; Viacava P; Poli A
Vet Pathol; 2002 Nov; 39(6):690-6. PubMed ID: 12450199
[TBL] [Abstract][Full Text] [Related]
35. Lymphangiogenesis in canine mammary tumours: a morphometric and prognostic study.
Sleeckx N; Van Brantegem L; Van den Eynden G; Fransen E; Casteleyn C; Van Cruchten S; Veldhuis Kroeze E; Van Ginneken C
J Comp Pathol; 2014; 150(2-3):184-93. PubMed ID: 24225342
[TBL] [Abstract][Full Text] [Related]
36. Tumor-infiltrating CD4
Franzoni MS; Brandi A; de Oliveira Matos Prado JK; Elias F; Dalmolin F; de Faria Lainetti P; Prado MCM; Leis-Filho AF; Fonseca-Alves CE
Res Vet Sci; 2019 Oct; 126():29-36. PubMed ID: 31425936
[TBL] [Abstract][Full Text] [Related]
37. Different role of COX-2 and angiogenesis in canine inflammatory and non-inflammatory mammary cancer.
Clemente M; Sánchez-Archidona AR; Sardón D; Díez L; Martín-Ruiz A; Caceres S; Sassi F; Dolores Pérez-Alenza M; Illera JC; Dunner S; Peña L
Vet J; 2013 Aug; 197(2):427-32. PubMed ID: 23489848
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of histological grading in noninflammatory canine mammary carcinomas in a prospective study with two-year follow-up: relationship with clinical and histological characteristics.
Peña L; De Andrés PJ; Clemente M; Cuesta P; Pérez-Alenza MD
Vet Pathol; 2013 Jan; 50(1):94-105. PubMed ID: 22688585
[TBL] [Abstract][Full Text] [Related]
39. Intratumoral CD3+ T-lymphocytes immunoexpression and its association with c-Kit, angiogenesis, and overall survival in malignant canine mammary tumors.
Carvalho MI; Pires I; Dias M; Prada J; Gregório H; Lobo L; Queiroga F
Anal Cell Pathol (Amst); 2015; 2015():920409. PubMed ID: 26346272
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical expression of estrogen receptor beta in normal and tumoral canine mammary glands.
Martín de las Mulas J; Ordás J; Millán MY; Chacón F; De Lara M; Espinosa de los Monteros A; Reymundo C; Jover A
Vet Pathol; 2004 May; 41(3):269-72. PubMed ID: 15133176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
